Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01321892 · ClinicalTrials.gov registry record
Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium
A clinical trial of Larynx and Squamous Cell Carcinoma of the Oral Cavity, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 64
- Enrollment target
- 1
- Study location
NCT01321892 is a study of Larynx and Squamous Cell Carcinoma of the Oral Cavity that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 64 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01321892, a study of Larynx and Squamous Cell Carcinoma of the Oral Cavity, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to collect information on whether images made using investigational microscopes can improve researchers' ability to evaluate and distinguish between normal and abnormal areas in tissue samples surgically removed from patients with squamous cell carcinoma. The microscopes being used in this study are considered investigational because they have not been approved by the United States Food and Drug Administration (FDA) for finding abnormal or pre-cancerous areas.
Conditions Studied
Study Locations (1)
New York
- Mount Sinai School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01321892
The ClinicalTrials.gov registry entry for NCT01321892 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Larynx appearing as the primary indexed condition, and to 0 interventions.
NCT01321892 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01321892 about?
NCT01321892 is a clinical study titled "Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium". The purpose of this research study is to collect information on whether images made using investigational microscopes can improve researchers' ability to evaluate and distinguish between normal and abnormal areas in tissue samples surgically removed from patients with squamous cell carcinoma. The mi...
What is the current status of trial NCT01321892?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2009-06. Estimated completion is 2012-05.
What conditions does trial NCT01321892 study?
This clinical trial studies the following conditions: Larynx, Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Hypopharynx.
Who is sponsoring clinical trial NCT01321892?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01321892 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Larynx
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.